FDA

News

Study points to weaknesses in FDA accelerated approval path

Less than half of the cancer therapies that were granted accelerated approval by the FDA between 2013 and 2017 showed a clinical benefit in a confirmatory trial within the

News

$Eko Health and ejection fraction$

FDA clears AI that detects heart failure using a stethoscope

The FDA has cleared an artificial intelligence algorithm that can detect signs of heart failure in seconds using a digital stethoscope during a standard physical exam.

Market Access

Aduhelm and an expensive failure to launch

Biogen’s treatment for Alzheimer’s was initially regarded as a major treatment breakthrough.

News

FDA okays Italfarmaco’s non-steroidal DMD therapy Duvyzat

Italfarmaco’s oral HDAC inhibitor givinostat has been approved in the US as a treatment for Duchenne muscular dystrophy (DMD), becoming the first non-steroidal option for

News

Idorsia first-in-class hypertension drug gets FDA okay

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist

News

Iclusig gets FDA nod as frontline therapy for rare leukaemia

Takeda’s Iclusig has become the first targeted therapy approved by the FDA for use alongside chemotherapy as a first-line therapy for a rare form of acute lymphoblastic le

Study points to weaknesses in FDA accelerated approval path

FDA clears AI that detects heart failure using a stethoscope

Aduhelm and an expensive failure to launch

FDA okays Italfarmaco’s non-steroidal DMD therapy Duvyzat

Idorsia first-in-class hypertension drug gets FDA okay

Iclusig gets FDA nod as frontline therapy for rare leukaemia

From Automation to Decision Intelligence: The Next Operating...

Discover a new era of healthcare panel engagement: Grounded ...

FDA

Editor's Picks